The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

The present invention is directed to methods for the preparation of eremophila-1(10)-11(13)-dien-12,8-olide (EPD) and analogues thereof.

The present invention is directed to methods for the preparation of eremophila-1(10)-11(13)-dien-12,8-olide (EPD) and analogues thereof.

Embodiments are directed to N.sub.3-kethoxal reagents and derivatives thereof, and related methods that allow fast and reversible labeling of single-stranded nucleic acids in live cells. By way of example, one aspect is directed to a process for reversible labeling of single-stranded guanine bases in live cells, which results in an effective in vivo method for transcriptome-wide RNA secondary structure mapping and RNA G-quadruplex prediction.

Embodiments are directed to N.sub.3-kethoxal reagents and derivatives thereof, and related methods that allow fast and reversible labeling of single-stranded nucleic acids in live cells. By way of example, one aspect is directed to a process for reversible labeling of single-stranded guanine bases in live cells, which results in an effective in vivo method for transcriptome-wide RNA secondary structure mapping and RNA G-quadruplex prediction.

The invention provides an artificially synthesized single sphingosine lipid and use of delivering a nucleic acid thereof. More particularly, the invention provides Use or method for delivering a nucleic acid to a cell or a subject using a compound of Formula (I), a stereoisomer or a pharmaceutical acceptable salt thereof, or a combination comprising a compound of Formula (I), a stereoisomer or a pharmaceutical acceptable salt thereof,

##STR00001##

The present invention relates to a method for manufacturing a catalyst for synthesizing a fatty acid methyl or ethyl ester and a method for manufacturing a fatty acid methyl or ethyl ester using the catalyst. It provides a method for manufacturing a solid catalyst by mixing the oxides of manganese as active catalytic material and the soda lime glass as carrier wherein the content of the oxides of manganese is in the range of 0.1 w % to 70 w %, molding the mixture to spherical or cylindrical shape and sintering the molded catalyst. It also provides a method for manufacturing fatty acid methyl or ethyl ester with high purity by reacting fatty acid or a mixture of oil and fatty acid with methanol or ethanol by placing the solid catalyst in the reactor.

The present invention relates to a plasticizer composition and a preparation method therefor and, more specifically, to a plasticizer composition, which contains an anhydrosugar alcohol monoester, an anhydrosugar alcohol diester, and a sugar alcohol ester at a specific content ratio and has improved plasticity and excellent storage stability, and to a preparation method therefor.

The present invention relates to a plasticizer composition and a preparation method therefor and, more specifically, to a plasticizer composition, which contains an anhydrosugar alcohol monoester, an anhydrosugar alcohol diester, and a sugar alcohol ester at a specific content ratio and has improved plasticity and excellent storage stability, and to a preparation method therefor.

The present disclosure relates to a system and a method for continuously purifying a reaction product of esterification, where the system includes a neutralizer, a distiller, and a product purifier. Through the present system and the method, it is possible to perform a continuous purification process efficiently, and to reduce lower alcohol wastewater generated during purification.